We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this year, said Dr Raches Ella.